NINLARO
NDC 63020-400, ixazomib, capsule, from Takeda Pharmaceuticals America, Inc..
- Product NDC
- 63020-400
- Status
- Listed
- Labeler
- Takeda Pharmaceuticals America, Inc.
- Dosage form
- CAPSULE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA208462
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/63020-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- IXAZOMIB CITRATE4 mg/1
Pharmacologic classes
Proteasome Inhibitor [EPC]; Proteasome Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 63020-400-01 | 63020040001 | 1 CAPSULE in 1 BLISTER PACK (63020-400-01) |
| 63020-400-02 | 63020040002 | 1 BLISTER PACK in 1 CARTON (63020-400-02) / 3 CAPSULE in 1 BLISTER PACK (63020-400-03) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/038f2461-834b-4488-9ebd-863c83eef5a7
Use it
Look up 63020-400 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/63020-400 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 63020-400. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.